Concepedia

Huaxing Pei

HP

3

Publications

64

Citations

3

H-Index

2009

Active since

Affiliations

Eli Lilly (United States)(Current)

Huaxing Pei is an author at Eli Lilly (United States) specializing in biomolecular engineering, medicine, and drug discovery.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesBiomolecular EngineeringCatalysisChemistryEngineeringCell Biology

Publications per year

2009–2018

3

Publications

3

Abstract 955: LY3200882, a novel, highly selective TGFβRI small molecule inhibitor

Huaxing Pei, Saravanan Parthasarathy, Sajan Joseph et al. · Cancer Research · 2017 · 28 citations

Drug Target, Immunotherapeutics, Cancer Biology +21

One-Pot Synthesis of Lactams Using Domino Reactions: Combination of Schmidt Reaction with Sakurai and Aldol Reactions

Chan Woo Huh, G.K. Somal, C. E. Katz et al. · The Journal of Organic Chemistry · 2009 · 20 citations · Full text

Engineering, Sakurai Reaction, Organic Chemistry +16

Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT

Saravanan Parthasarathy, Kenneth J. Henry, Huaxing Pei et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 16 citations · Full text

Medicinal Chemistry, Chiral Dihydropyridopyrimidinones, Pharmaceutical Science +11

Rows per page

1–3 of 3